Global In Vitro Lung Model Market Overview 2020-2026

• Posted by aarti ghodke May 22, 2021 - Filed in Society - #Global In Vitro Lung Model Market  - 118 views

   

  The Global In Vitro Lung Model Market size was valued at USD 166 million in 2019 and is expected to reach USD $483 million by 2026, at a CAGR of 18.2% during the forecast period.

   

  The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.

  Global In Vitro Lung Model Market Overview:

   

  In vitro models of the human lung are also likely to provide powerful platforms for large-scale screens, molecular-level analysis of cell-cell interactions, and the potential to study or treat lung disorders with personalized medicine.

   

  The report covers the current estimate and forecast for in Vitro Lung Model Market on a global and regional level. The report provides an in-depth analysis of the In Vitro Lung Model Market for the period 2019 – 2026, wherein 2019 is the base year and the period from 2020 to 2026 is the forecast period. Data for 2016- 2018 has been included as historical information.

   

  The study provides a detailed perspective on market growth, throughout the forecast period in terms of revenue estimates (in US$ MN), across different geographies, which include North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and Latin America (LATAM).

   

  The report provides qualitative and quantitative insights on the In Vitro Lung Model industry trends and a detailed analysis of the market size and growth rate of all segments in the market. The market is segmented by Type, Application, and Region.

   

  Key players covered in the report of global in vitro lung model market are Epithelix, MatTek Corporation, Lonza, ATCC, InSphero, Emulate, AlveoliX AG, Oncotheis, Insphero, TissUse, Mimetas, CN Bio Innovations, Thermo Fisher Scientific Inc., PromoCell GmbH, Merck KGaA, Hoziron Discovery Group plc.

  In Vitro Lung Model Market Dynamics:

   

  Many differences between animal and human lung physiology, create an unmet need for human lung model systems that can complement animal models to improve our understanding of human lung physiology. Upsurge population suffering from lung fibrosis & emphysema, lung cancer, and other respiratory disorders led the research into in vitro lung model.

   

  The ability of in vitro lung model to relate and accurately recapitulate complexities of human biology is to create the opportunities for the growth of global market by improving the understanding for cell mechanism. Hence, this in vitro lung model increases the ability to treat patients having lung diseases. Growing interest of scientists in cell biology and biochemistry study acts as a driver for growth of the global in-vitro lung model market.

   

  2D Cell Model segment commanded the largest market share for their positive results in treatment of bronchiectasis and pulmonary function disorders.

   

  Global In Vitro Lung Model Market

   

  The powerful research in the cell-cell interaction in in-vitro lung models creates opportunities for the global in vitro lung model market in the forecast period. 2D cell lung model examines cell-based responses, physiologic functions, drug toxicity, and drug responses, which led to the growth of the global market results in a growing number of treatments and surgeries for lung diseases.

   

  The drug screening & toxicology segment is expected to expand at a significant CAGR of 9.0% during the forecast period.

   

  An increase in research and development of new drugs and rising demand for in vitro lung models for lung transplantation are anticipated to grow the global market. Government facilities and expenditure for research and development across the pharmaceutical sector, biochemistry labs, national cell science centers are also boosting the global long model market. Human model systems that reliably and accurately recapitulate the complexities of human biology in vitro should help to improve our understanding of and ability to treat human lung disease.

   

  Europe commanded the largest market share of xx % by 2026.

   

  Global In Vitro Lung Model Market 1

   

  Europe commanded the largest market share of XX % during the forecast period for their availability of lots of literature studies for in vitro lung models. An increase in research funding from various organizations and a rise in research and development activities by various pharmaceutical and biotechnology companies propel the growth of the global in-vitro lung model market in Europe. Rising cases of asthma, lung cancer, and COPD are the major factors driving in vitro lung model market.

   

  Global In Vitro Lung Model Market 2

  Key Players Covered in the Global in Vitro Lung Model Market

   

  • Epithelix
  • MatTek Corporation
  • Lonza
  • ATCC
  • InSphero
  • Emulate
  • AlveoliX AG
  • Oncotheis
  • Insphero
  • TissUse
  • Mimetas
  • CN Bio Innovations
  • Thermo Fisher Scientific Inc.
  • PromoCell GmbH
  • Merck KGaA
  • Hoziron Discovery Group plc

   

  For More Information Vist : https://www.maximizemarketresearch.com/market-report/global-in-vitro-lung-model-market/85854/

  Report Is Submitted By : Maximize Market Research Company 

   

                 

   

   

   

   

   

   

   

   

   

   

  
  Customization of the report:

   

   

   

   

   

   

   

  Maximize Market Research of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

   

   

   

   

  About Maximize Market Research:

   

   

   

  Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & C

  ommunications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.